1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Embolotherapy Product Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Embolization Microspheres
1.2.3 Embolization Particles
1.2.4 Embolization Coil
1.2.5 Liquid Embolic Agents
1.2.6 Auxiliary Embolic Material
1.2.7 Others
1.3 Market by Application
1.3.1 Global Embolotherapy Product Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Oncology
1.3.3 Peripheral Vascular Disease (PVD)
1.3.4 Neurology
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Embolotherapy Product Market Perspective (2018-2029)
2.2 Embolotherapy Product Growth Trends by Region
2.2.1 Global Embolotherapy Product Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Embolotherapy Product Historic Market Size by Region (2018-2023)
2.2.3 Embolotherapy Product Forecasted Market Size by Region (2024-2029)
2.3 Embolotherapy Product Market Dynamics
2.3.1 Embolotherapy Product Industry Trends
2.3.2 Embolotherapy Product Market Drivers
2.3.3 Embolotherapy Product Market Challenges
2.3.4 Embolotherapy Product Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Embolotherapy Product Players by Revenue
3.1.1 Global Top Embolotherapy Product Players by Revenue (2018-2023)
3.1.2 Global Embolotherapy Product Revenue Market Share by Players (2018-2023)
3.2 Global Embolotherapy Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Embolotherapy Product Revenue
3.4 Global Embolotherapy Product Market Concentration Ratio
3.4.1 Global Embolotherapy Product Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Embolotherapy Product Revenue in 2022
3.5 Embolotherapy Product Key Players Head office and Area Served
3.6 Key Players Embolotherapy Product Product Solution and Service
3.7 Date of Enter into Embolotherapy Product Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Embolotherapy Product Breakdown Data by Type
4.1 Global Embolotherapy Product Historic Market Size by Type (2018-2023)
4.2 Global Embolotherapy Product Forecasted Market Size by Type (2024-2029)
5 Embolotherapy Product Breakdown Data by Application
5.1 Global Embolotherapy Product Historic Market Size by Application (2018-2023)
5.2 Global Embolotherapy Product Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Embolotherapy Product Market Size (2018-2029)
6.2 North America Embolotherapy Product Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Embolotherapy Product Market Size by Country (2018-2023)
6.4 North America Embolotherapy Product Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Embolotherapy Product Market Size (2018-2029)
7.2 Europe Embolotherapy Product Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Embolotherapy Product Market Size by Country (2018-2023)
7.4 Europe Embolotherapy Product Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Embolotherapy Product Market Size (2018-2029)
8.2 Asia-Pacific Embolotherapy Product Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Embolotherapy Product Market Size by Region (2018-2023)
8.4 Asia-Pacific Embolotherapy Product Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Embolotherapy Product Market Size (2018-2029)
9.2 Latin America Embolotherapy Product Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Embolotherapy Product Market Size by Country (2018-2023)
9.4 Latin America Embolotherapy Product Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Embolotherapy Product Market Size (2018-2029)
10.2 Middle East & Africa Embolotherapy Product Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Embolotherapy Product Market Size by Country (2018-2023)
10.4 Middle East & Africa Embolotherapy Product Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Detail
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Embolotherapy Product Introduction
11.1.4 Medtronic Revenue in Embolotherapy Product Business (2018-2023)
11.1.5 Medtronic Recent Development
11.2 Boston Scientific
11.2.1 Boston Scientific Company Detail
11.2.2 Boston Scientific Business Overview
11.2.3 Boston Scientific Embolotherapy Product Introduction
11.2.4 Boston Scientific Revenue in Embolotherapy Product Business (2018-2023)
11.2.5 Boston Scientific Recent Development
11.3 Terumo
11.3.1 Terumo Company Detail
11.3.2 Terumo Business Overview
11.3.3 Terumo Embolotherapy Product Introduction
11.3.4 Terumo Revenue in Embolotherapy Product Business (2018-2023)
11.3.5 Terumo Recent Development
11.4 Penumbra
11.4.1 Penumbra Company Detail
11.4.2 Penumbra Business Overview
11.4.3 Penumbra Embolotherapy Product Introduction
11.4.4 Penumbra Revenue in Embolotherapy Product Business (2018-2023)
11.4.5 Penumbra Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Detail
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Embolotherapy Product Introduction
11.5.4 Johnson & Johnson Revenue in Embolotherapy Product Business (2018-2023)
11.5.5 Johnson & Johnson Recent Development
11.6 Grandpharma (Sirtex)
11.6.1 Grandpharma (Sirtex) Company Detail
11.6.2 Grandpharma (Sirtex) Business Overview
11.6.3 Grandpharma (Sirtex) Embolotherapy Product Introduction
11.6.4 Grandpharma (Sirtex) Revenue in Embolotherapy Product Business (2018-2023)
11.6.5 Grandpharma (Sirtex) Recent Development
11.7 Merit Medical
11.7.1 Merit Medical Company Detail
11.7.2 Merit Medical Business Overview
11.7.3 Merit Medical Embolotherapy Product Introduction
11.7.4 Merit Medical Revenue in Embolotherapy Product Business (2018-2023)
11.7.5 Merit Medical Recent Development
11.8 Siemens Healthineers (Varian)
11.8.1 Siemens Healthineers (Varian) Company Detail
11.8.2 Siemens Healthineers (Varian) Business Overview
11.8.3 Siemens Healthineers (Varian) Embolotherapy Product Introduction
11.8.4 Siemens Healthineers (Varian) Revenue in Embolotherapy Product Business (2018-2023)
11.8.5 Siemens Healthineers (Varian) Recent Development
11.9 Stryker
11.9.1 Stryker Company Detail
11.9.2 Stryker Business Overview
11.9.3 Stryker Embolotherapy Product Introduction
11.9.4 Stryker Revenue in Embolotherapy Product Business (2018-2023)
11.9.5 Stryker Recent Development
11.10 Jiangsu Hengrui Medicine
11.10.1 Jiangsu Hengrui Medicine Company Detail
11.10.2 Jiangsu Hengrui Medicine Business Overview
11.10.3 Jiangsu Hengrui Medicine Embolotherapy Product Introduction
11.10.4 Jiangsu Hengrui Medicine Revenue in Embolotherapy Product Business (2018-2023)
11.10.5 Jiangsu Hengrui Medicine Recent Development
11.11 Cook Medical
11.11.1 Cook Medical Company Detail
11.11.2 Cook Medical Business Overview
11.11.3 Cook Medical Embolotherapy Product Introduction
11.11.4 Cook Medical Revenue in Embolotherapy Product Business (2018-2023)
11.11.5 Cook Medical Recent Development
11.12 Kaneka
11.12.1 Kaneka Company Detail
11.12.2 Kaneka Business Overview
11.12.3 Kaneka Embolotherapy Product Introduction
11.12.4 Kaneka Revenue in Embolotherapy Product Business (2018-2023)
11.12.5 Kaneka Recent Development
11.13 Meril Life Sciences
11.13.1 Meril Life Sciences Company Detail
11.13.2 Meril Life Sciences Business Overview
11.13.3 Meril Life Sciences Embolotherapy Product Introduction
11.13.4 Meril Life Sciences Revenue in Embolotherapy Product Business (2018-2023)
11.13.5 Meril Life Sciences Recent Development
11.14 Peijia Medical
11.14.1 Peijia Medical Company Detail
11.14.2 Peijia Medical Business Overview
11.14.3 Peijia Medical Embolotherapy Product Introduction
11.14.4 Peijia Medical Revenue in Embolotherapy Product Business (2018-2023)
11.14.5 Peijia Medical Recent Development
11.15 Wallaby Medical
11.15.1 Wallaby Medical Company Detail
11.15.2 Wallaby Medical Business Overview
11.15.3 Wallaby Medical Embolotherapy Product Introduction
11.15.4 Wallaby Medical Revenue in Embolotherapy Product Business (2018-2023)
11.15.5 Wallaby Medical Recent Development
11.16 MicroPort Scientific Corporation
11.16.1 MicroPort Scientific Corporation Company Detail
11.16.2 MicroPort Scientific Corporation Business Overview
11.16.3 MicroPort Scientific Corporation Embolotherapy Product Introduction
11.16.4 MicroPort Scientific Corporation Revenue in Embolotherapy Product Business (2018-2023)
11.16.5 MicroPort Scientific Corporation Recent Development
11.17 Weihai Visee Medical Devices
11.17.1 Weihai Visee Medical Devices Company Detail
11.17.2 Weihai Visee Medical Devices Business Overview
11.17.3 Weihai Visee Medical Devices Embolotherapy Product Introduction
11.17.4 Weihai Visee Medical Devices Revenue in Embolotherapy Product Business (2018-2023)
11.17.5 Weihai Visee Medical Devices Recent Development
11.18 Beijing Taijieweiye Technology
11.18.1 Beijing Taijieweiye Technology Company Detail
11.18.2 Beijing Taijieweiye Technology Business Overview
11.18.3 Beijing Taijieweiye Technology Embolotherapy Product Introduction
11.18.4 Beijing Taijieweiye Technology Revenue in Embolotherapy Product Business (2018-2023)
11.18.5 Beijing Taijieweiye Technology Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
| ※参考情報 塞栓療法製品は、医療の分野において重要な役割を果たす治療法の一つです。この療法は、血管を塞ぐことによって血流を制御し、特定の病態に対する治療効果をもたらします。以下では、塞栓療法製品の概念について、定義、特徴、種類、用途、関連技術の観点から述べます。 塞栓療法の定義は、血管を塞ぐことによって血流を制限したり、血流を完全に遮断したりする手法を指します。これは主に、腫瘍や動静脈奇形、出血といった病状に対して行われます。塞栓療法は、カテーテルを用いて行われることが一般的で、目的の血管に塞栓物質を注入することによってあらゆる薬剤や治療機器の効果を高めることが可能です。 特徴として、まず第一に、その非侵襲性があります。従来の手術に比べて身体への負担が少なく、入院期間も短縮されることが多いです。また、局所麻酔で行えるため、全身麻酔のリスクが回避されます。さらに、血管に直接作用するため、周囲の健康な組織に対する影響が最小限に抑えられ、その結果として合併症が少ないという利点があります。 塞栓療法製品は、使用される材料や技術の違いにより様々な種類が存在します。代表的な塞栓物質には、液体塞栓物質、固体塞栓物質、機械的塞栓物質などがあります。液体塞栓物質は、注入後に血管内で固まる性質を持ち、例えばポリビニルアルコール（PVA）や二酸化炭素のような物質が使用されます。固体塞栓物質は、微小なビーズやラテックスから作られ、主に血管を物理的に塞ぐことに寄与します。機械的塞栓物質は、血管内で展開され、塞栓を形成するデバイスであり、スプリングコイルやプラグが含まれます。 塞栓療法の用途は広範囲にわたります。腫瘍治療では、特に肝臓がんや子宮筋腫への適用が一般的です。腫瘍に対する塞栓療法は血流を遮断することで、腫瘍細胞への栄養供給を妨げ、細胞死を促進します。また、出血性疾患に対しては、動脈が破れて出血する場合に、その動脈を塞ぐことで出血を止める役割を果たします。さらに、動静脈奇形の治療では、異常な血管網を塞ぐことによって、症状の改善が期待されます。 関連技術としては、画像診断技術が挙げられます。塞栓療法は、CT（コンピュータ断層撮影）、MRI（磁気共鳴画像法）、超音波検査などの画像技術によって、治療の前後での血管の評価が可能です。このような画像技術は、塞栓対象の選定や治療効果の評価において不可欠な要素となります。また、カテーテル技術の進化も重要であり、より細いカテーテルや特別な先端が装備されたカテーテルにより、より複雑な血管にも治療が可能になっています。 塞栓療法製品は、今後ますます多様化し、進化していくことが期待されています。新しい材料や技術の開発により、より安全で効果的な治療が提供されるでしょう。これにより、さらなる適用範囲の拡大が見込まれますし、個々の患者に最適な治療方法の提供に寄与することが期待されます。 最終的に、塞栓療法は、現代医療において欠かせない治療法として位置づけられています。画像診断技術やカテーテル技術の革新が相まって、患者にとって安全で効果的な治療を提供できるよう、今後も研究と開発が進められることが望まれます。これにより、より多くの患者が恩恵を受け、生活の質が向上することが期待されます。 |
